These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7897837)

  • 1. [Characteristics of body surface mapping in the cases of idiopathic ventricular fibrillation].
    Toyoshima Y; Nirei T; Kasanuki H; Hosoda S
    Nihon Rinsho; 1995 Jan; 53(1):168-73. PubMed ID: 7897837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease.
    Kasanuki H; Ohnishi S; Ohtuka M; Matsuda N; Nirei T; Isogai R; Shoda M; Toyoshima Y; Hosoda S
    Circulation; 1997 May; 95(9):2277-85. PubMed ID: 9142005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Localization of the origin of idiopathic right ventricular tachycardia by body surface mapping].
    Kamakura S
    Nihon Rinsho; 1995 Jan; 53(1):151-60. PubMed ID: 7897836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy.
    Marrouche NF; Verma A; Wazni O; Schweikert R; Martin DO; Saliba W; Kilicaslan F; Cummings J; Burkhardt JD; Bhargava M; Bash D; Brachmann J; Guenther J; Hao S; Beheiry S; Rossillo A; Raviele A; Themistoclakis S; Natale A
    J Am Coll Cardiol; 2004 May; 43(9):1715-20. PubMed ID: 15120835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular fibrillation during no-flow global ischemia in isolated rabbit hearts.
    Wu TJ; Lin SF; Hsieh YC; Ting CT; Chen PS
    J Cardiovasc Electrophysiol; 2006 Oct; 17(10):1112-20. PubMed ID: 16879627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic identification of abnormal ventricular depolarization and repolarization in patients with idiopathic ventricular fibrillation.
    Peeters HA; Sippensgroenewegen A; Wever EF; Potse M; Daniëls MC; Grimbergen CA; Hauer RN; Robles de Medina EO
    J Am Coll Cardiol; 1998 May; 31(6):1406-13. PubMed ID: 9581742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the location of myocardial infarction on the spectral characteristics of ventricular fibrillation.
    Sánchez-Muñoz JJ; Rojo-Alvarez JL; García-Alberola A; Everss E; Requena-Carrión J; Ortiz M; Alonso-Atienza F; Valdés-Chavarri M
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):660-5. PubMed ID: 18507537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study.
    Knecht S; Sacher F; Wright M; Hocini M; Nogami A; Arentz T; Petit B; Franck R; De Chillou C; Lamaison D; Farré J; Lavergne T; Verbeet T; Nault I; Matsuo S; Leroux L; Weerasooriya R; Cauchemez B; Lellouche N; Derval N; Narayan SM; Jaïs P; Clementy J; Haïssaguerre M
    J Am Coll Cardiol; 2009 Aug; 54(6):522-8. PubMed ID: 19643313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance.
    Rosso R; Kogan E; Belhassen B; Rozovski U; Scheinman MM; Zeltser D; Halkin A; Steinvil A; Heller K; Glikson M; Katz A; Viskin S
    J Am Coll Cardiol; 2008 Oct; 52(15):1231-8. PubMed ID: 18926326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Body surface mapping in patients with hypertrophic cardiomyopathy (HCM)].
    Katayama K; Kamakura S
    Nihon Rinsho; 1995 Jan; 53(1):214-8. PubMed ID: 7897846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for multiple mechanisms in human ventricular fibrillation.
    Nash MP; Mourad A; Clayton RH; Sutton PM; Bradley CP; Hayward M; Paterson DJ; Taggart P
    Circulation; 2006 Aug; 114(6):536-42. PubMed ID: 16880326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation of idiopathic ventricular fibrillation guided by noncontact mapping.
    Betts TR; Yue A; Roberts PR; Morgan JM
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):957-9. PubMed ID: 15333096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrocardiographic findings in arrhythmogenic right ventricular dysplasia (ARVD) evaluated by body surface mapping].
    Okano Y
    Nihon Rinsho; 1995 Jan; 53(1):230-8. PubMed ID: 7897849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of ventricular vulnerable period and ventricular fibrillation threshold by use of T-wave shocks in patients undergoing implantation of cardioverter/defibrillators.
    Hou CJ; Chang-Sing P; Flynn E; Martinez L; Peterson J; Ottoboni LK; Liem LB; Sung RJ
    Circulation; 1995 Nov; 92(9):2558-64. PubMed ID: 7586357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study.
    Aiba T; Shimizu W; Hidaka I; Uemura K; Noda T; Zheng C; Kamiya A; Inagaki M; Sugimachi M; Sunagawa K
    J Am Coll Cardiol; 2006 May; 47(10):2074-85. PubMed ID: 16697328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in body surface potential distributions induced by isoproterenol and Na channel blockers in patients with the Brugada syndrome.
    Izumida N; Asano Y; Doi S; Wakimoto H; Fukamizu S; Kimura T; Ueyama T; Sakurada H; Kawano S; Sawanobori T; Hiraoka M
    Int J Cardiol; 2004 Jun; 95(2-3):261-8. PubMed ID: 15193830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with brugada syndrome: multicenter study in Japan.
    Takagi M; Yokoyama Y; Aonuma K; Aihara N; Hiraoka M;
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1244-51. PubMed ID: 17900255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular fibrillation frequency.
    Callihan J; Roeder R; Geddes LA; Otlewski M; Kemeny A
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):610-2. PubMed ID: 16008794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.